Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

MicroT Microbiota-T cell interactions - antigen-specificity and regulation in health and disease

Coordinator
Universitatsklinikum Schleswig-Holstein, Germany
Runs
1 July 2022 to 30 June 2027
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101040023

What the project is doing

In the project's own words, from its summary on CORDIS.

The microbiota has an enormous influence on human health. CD4+ T cells play a central role in controlling the interaction with the microbiota. By specifically reacting against individual microbial species, T cells enable a mutualistic co-existence with microbes. Inappropriate T cell responses against microbes are in turn associated with inflammatory diseases. Thus, the combination of T cell specificity and functionality form the key determinant for physiological versus pathological host-microbiota interactions.

So far, research on T cell-microbiota interaction is almost exclusively focussed on functional T cell subsets, whereas antigen-specificity is rarely addressed. This is a significant roadblock for developing targeted therapeutic interventions for microbiota-associated diseases. The interaction with the microbiota poses two particular challenges for adaptive immunity: first, the extremely high diversity of microbial species, and thus potential T cell targets; second, microbes are persistent and thus probably encountered chronically.

Currently, we do not know (1) which microbes are targets of specific T cell reactivity in humans, (2) how the (chronic) interaction with the huge number of different microbial species is regulated by T cell specificity and function, and (3) how alterations of these parameters contribute to microbiota-associated diseases. I developed a highly sensitive technology to detect and deeply characterize microbe-specific T cells directly from human samples.

MicroT will identify microbial target species of human T cells and unravel the molecular mechanisms regulating chronic interaction of T cells with the highly diverse microbiota. I will define the impact of specific T cell-microbiota interactions on chronic inflammatory diseases and upon ageing. Answering these fundamental questions of microbiota-T cell interaction will identify specific immune or microbial targets as an essential basis for rational development of novel targeted therapies.

Topics

Who is involved

OrganisationCityCountryRole
Universitatsklinikum Schleswig-HolsteinLübeckGermanyCoordinator
Christian-Albrechts-Universitaet Zu KielKielGermanyThird party

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI